Incorporated in 2008, Birla Pacific Medspa Limited is an India based healthcare provider.

Birla Pacific Medspa is a joint venture of Yash Birla Group, a Rs 30 billion group of over 20 diversified companies and Pacific Healthcare, East Asias leading healthcare provider, with healthcare facilities in Singapore, Hong Kong, and China. Birla Pacific Medspa provides beauty related medical procedures in India. Using state-of-the-art equipments, the internationally qualified panel of doctors provides patient centric solutions and offers the latest and safest treatments. Company operates it healthcare centers under the brand name EVOLVE. Company operates 3 healthcare centers in Mumbai and has 2 franchises in Thane and Chennai. Company's expertise includes Cosmetic Dermatology, Cosmetic & Plastic Surgery, General & Specialist Dentistry and Maxillo Facial Prosthesis. It has introduced i-lipo, a non-surgical inch loss treatment, for the first time in India.

Company Promoters:
Company is promoted by Mr. Yashovardhan Birla and one of his group companies, Birla Wellness & Healthcare Private Limited.

Objects of the Issue:

The objects of the issue are 1. 2. 3. 4. 5. To meet the capital expenditure towards establishing 55 outlets of Evolve Medspa across various cities and places. To meet expenses towards brand promotion. To meet the working capital requirements for running the centers. To meet Issue related expenses. To enlist the Company's Shares on Bombay Stock Exchange Limited (BSE).

Issue Detail:
Issue Open: Jun 20, 2011 - Jun 23, 2011 Issue Type: 100% Book Built Issue IPO Issue Size: 65,175,000 Equity Shares of Rs. 10 Issue Size: Rs. 65.18 Crore Face Value: Rs. 10 Per Equity Share Issue Price: Rs. 10 - Rs. 11 Per Equity Share Market Lot: 500 Shares Minimum Order Quantity: 500 Shares Listing At: BSE

Birla Pacific Medspa Ltd IPO Grading

BWR (Brickworks Ratings India Pvt Ltd) has assigned an IPO Grade 2 to Birla Pacific Medspa IPO. This means as per BWR, company has 'Below Average Fundamentals'. BWR assigns IPO grading on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Read Birla Pacific Medspa IPO Grading Report

Issue Subscription Detail / Current Bidding Status

Number of Times Issue is Subscribed (BSE + NSE) Qualified Non Retail Institutional Institutional Individual Total Buyers (QIBs) Investors (NIIs) Investors (RIIs) 32,587,500 9,776,250 22,811,250 65,175,000 0.3300 0.0000 0.2500 0.2500 0.6700 0.0000 0.3700 0.4600 0.9900 0.0000 0.5800 0.7000 1.0400 0.1700 1.8200 1.1800

As on Date & Time Shares Offered / Reserved Day 1 - Jun 20, 2011 17:00 IST Day 2 - Jun 21, 2011 17:00 IST Day 3 - Jun 22, 2011 17:00 IST Day 4 - Jun 23, 2011 17:00 IST

Birla Pacific Medspa Limited

THE YASH BIRLA GROUP Our company was originally Incorporated in the name of 'Birla Pacific Medspa Priavte Limited.' on July 15,2008 under the Companies Act, 1956 in the State of Maharashtra. The company was converted to a Public Company and the name was consequently changed to 'Birla Pacific Medspa Limited' and a fresh Certificate of Incorporation consequent to Change of Name was obtained from Registrar of Companies, Maharashtra on 14th July, 2010. The Corporate Identification Number of our Company is U85100MH2008PLC184689. The Company is promoted by Mr. Yashovardhan Birla and Birla Wellness & Healthcare Pvt. Limited, a Yash Birla Group company.

BASIS OF ALLOTMENT
PUBLIC ISSUE OF 65,175,000 EQUITY SHARES OF RS.10/- EACH AT A PRICE OF RS. 10/- PER EQUITY SHARE FOR CASH AGGREGATING TO RS. 6517.50 LACS (THE "ISSUE"), BY BIRLA PACIFIC MEDSPA LIMITED (THE "COMPANY" OR THE "ISSUER"). THE ISSUE CONSTITUTES 58.12% OF THE FULLY DILUTED POST ISSUE PAID-UP CAPITAL OF OUR COMPANY.

THE ISSUE PRICE IS ONE TIME OF THE FACE VALUE

The equity shares of the Company are proposed to be listed on Bombay Stock Exchange Limited ("BSE") and Trading is expected to commence on 7th july 2011

ISSUE PRICE: RS. 10/- PER EQUITY SHARE OF THE FACE VALUE OF RS. 10/- EACH BID/ISSUE OPENED ON JUNE 20, 2011 CLOSED ON JUNE 23, 2011
This Issue was made through a 100% Book Building Process in terms of regulation 26(2)(a)(i) and b(i) of SEBI (ICDR) Regulations, 2009, as amended from time to time, whereby at least 50% of the Issue was to be allocated to Qualified Institutional Buyers (QIBs) on a proportionate basis, subject to valid bids being received at or above the Issue Price. 5% of the QIB Portion was available for allocation on proportionate basis to Mutual Funds only and the remaining Net QIB portion was available for allocation on a proportionate basis to all Qualified Institutional Buyers, including Mutual Funds, subject to valid bids being received at or above Issue Price. Further, upto 15% of the Issue was available for allocation on a proportionate basis to Non Institutional Bidders and upto 35% of the Issue was available for allocation on a proportionate basis to Retail Individual Bidders, subject to valid bids being received at or above the Issue Price. The Issue received 3138 applications for 74670000 equity shares resulting in 1.15 times subscription. The details of the applications received in the Issue from Qualified Institutional Buyers, Non-Institutional and Retail Individual Investor categories are as under: (Before technical rejections) Category Qualified Institutional Investors Non Institutional Investors Retail Individual Investors Total No. of Applications 5 5 3128 3138 No. of Shares 33812000 1614000 39244000 74670000 No. of times Subscription 1.03 0.16 1.72 1.15

A B C

Final Demand A summary of the final demand as per BSE and NSE as on the Bid/Issue Closing date at different bid prices is as under: Bid Price 10 11 No. of Shares 32819500 6674000 % to Total 42.58 8.66 Cumulative Total 77071000 44251500 Cumulative % to Total 100.00 57.42

Cutoff Total

37577500 77071000

48.76 100

37577500

48.76

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being The Bombay Stock Exchange Limited ("BSE") on June 30,2011 The Board of Directors of the Company at its Meeting held at Mumbai, on June 30,2011 allotted the Equity Shares to the successful applicants. Details of valid applications received & allotments done are as under: A. Allotment to Retail Individual Investors, including ASBA applications (After Technical Rejections) The Basis of Allotment to the Retail Individual Investors, who have bid at cut-off or at the Issue Price of Rs. 10/- per Equity Share, was finalized in consultation with BSE. The category was subscribed 1.26 times. As per the Prospectus, the spill over portion from QIB Category was 3591228 equity shares and 3346522 from Non Institutional Category. The total number of equity shares allotted in this category is 29750366 Equity Shares (including 1366 excess shares allotted for rounding off) to 2966 successful applicants. Out of the valid SCSB ASBA applications, 8910549 equity shares were allotted to 1057 successful SCSB ASBA applicants. Out of the valid Syndicate ASBA applications, 226626 equity shares were allotted to 18 successful Syndicate ASBA applicants. The category-wise details of the Basis of Allotment are as under: No. of Applications 524 199 36 37 13 10 2 5 21 17 1 1 2 2 3 192 2 5 1 1 1 1 2 1 4 1 2 2003 1 3090 % to Total 16.96 6.44 1.17 1.20 0.42 0.32 0.06 0.16 0.68 0.55 0.03 0.03 0.06 0.06 0.10 6.21 0.06 0.16 0.03 0.03 0.03 0.03 0.06 0.03 0.13 0.03 0.06 64.82 0.03 100.00 Shares Applied 262000 199000 54000 74000 32500 30000 7000 20000 94500 85000 5500 6000 14000 15000 24000 1728000 19000 50000 10500 11500 12000 12500 27000 14000 60000 15500 32000 36054000 20000 38988500 % to Total 0.67 0.51 0.14 0.19 0.08 0.08 0.02 0.05 0.24 0.22 0.01 0.02 0.04 0.04 0.06 4.43 0.05 0.13 0.03 0.03 0.03 0.03 0.07 0.04 0.15 0.04 0.08 92.47 0.05 100.00 No. of Shares allocated 500 763 1145 1526 1908 2289 2671 3052 3434 3815 4197 4578 5341 5723 6104 6867 7249 7630 8012 8775 9156 9538 10301 10682 11445 11827 12209 13735 15260 Total No. of Shares allocated 200000 151837 41220 56462 24804 22890 5342 15260 72114 64855 4197 4578 10682 11446 18312 1318464 14498 38150 8012 8775 9156 9538 20602 10682 45780 11827 24418 27511205 15260 29750366

Category 500 1000 1500 2000 2500 3000 3500 4000 4500 5000 5500 6000 7000 7500 8000 9000 9500 10000 10500 11500 12000 12500 13500 14000 15000 15500 16000 18000 20000 Total:

Ratio 29:38 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1

B. Allotment to Non Institutional Investors, including ASBA applications (After Technical Rejections) The basis of allotment to Non Institutional Investors, who have bid at the Issue Price of Rs.10/- per Equity Share, was finalized in consultation with BSE. The category was subscribed 0.16 times. The total number of equity shares allotted in this category is 1614000 to 5 successful applicants. All the applicants in this category have been given firm allotment. There were five applications under ASBA process for 1614000 equity shares. C. Allotment to QIBs (After Technical Rejections) The QIBs in this issue had 5 applications which were received through ASBA. The category was subscribed 1.03 times. The total number of equity shares allotted in this category is 33812000 to 5 successful applicants. All the applicants in this category have been given firm allotment. Dates of dispatch of Refund Orders, Credit to beneficiary Accounts, Refund instructions and Listing details Activity Date of Completion Approval of Basis of Allotment by BSE June 30, 2011 Dispatch of Allotment Advices, Refund Orders and ECS Intimation Note July 04, 2011 Refund Instructions to the Clearing System (in case of Refunds through NECS system) July 04, 2011 Instructions to the Self Certified Syndicate Banks (SCSBs) by the registrar July 01, 2011 Listing Application to BSE July 04, 2011 Credit to beneficiary Accounts July 02, 2011 Refunds have been made through NECS into the Bank Accounts of the applicants, as registered with the depositories. For other applicants Refund Orders have been dispatched to their address as registered with the depositories. In case the same is not received within ten days, investors may contact at the address given below. The Refund Orders have been over-printed with the Bank Mandate details as registered, if any, with the depositories. The shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The company has obtained listing and trading permission from Bombay Stock Exchange Limited and trading in the equity shares of the company is expected to commence on 7th July2011. INVESTORS PLEASE NOTE This details of the allotment made would be hosted on the website of Registrars to the Issue, Adroit Corporate Services Private Limited at www.adroitcorporate.com